SCHEMBL224889

SCHEMBL224889

Cc1cc(Cc2cc(C)c(O)cc2C)c(C)cc1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
HIF1A Q16665 3/20 0.52
HSD17B10 Q99714 3/20 0.52
CYP2D6 P10635 2/20 0.52
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
CYP1A2 P05177 2/20 0.52
ALOX15 P16050 2/20 0.52
NPSR1 Q6W5P4 2/20 0.52
KDM4E B2RXH2 1/20 0.52
CYP3A4 P08684 1/20 0.52
MAPT P10636 1/20 0.52
G6PD P11413 1/20 0.52
PKM P14618 1/20 0.52
HPGD P15428 1/20 0.52
ALOX12 P18054 1/20 0.52
MAPK1 P28482 1/20 0.52
CCR6 P51684 1/20 0.52
ESR1 P03372 2/20 0.44
ESR2 Q92731 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29713830 1.00 ALDH1A1 (0.52) ALDH1A1HIF1AHSD17B10CYP2D6CYP2C9
SCHEMBL8346860 0.93 ALDH1A1 (0.46) ALDH1A1HIF1AHSD17B10CYP2D6CYP2C9
SCHEMBL14181474 0.93 ALDH1A1 (0.46) ALDH1A1HIF1AHSD17B10CYP2D6CYP2C9
SCHEMBL13609020 0.87 AMY1A (0.58) ALDH1A1HIF1AHSD17B10CYP2D6CYP2C9
SCHEMBL30375265 0.87 AMY1A (0.58) ALDH1A1HIF1AHSD17B10CYP2D6CYP2C9
SCHEMBL18121261 0.87 HIF1A (0.42) ALDH1A1HIF1AHSD17B10CYP2D6CYP2C9
SCHEMBL29941774 0.87 AMY1A (0.58) ALDH1A1HIF1AHSD17B10CYP2D6CYP2C9
SCHEMBL278491 0.87 AMY1A (0.58) ALDH1A1HIF1AHSD17B10CYP2D6CYP2C9
SCHEMBL4054188 0.86 ALDH1A1 (0.48) ALDH1A1HIF1AHSD17B10CYP2D6CYP2C9
SCHEMBL4063126 0.85 SHBG (0.48) ALDH1A1HIF1AHSD17B10CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 382 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828284-B1 SULPHONATED MULTIBLOCK COPOLYMER AND ELECTROLYTE MEMBRANE USING THE SAME LG CHEMICAL LTD (KR) 2012-06-13 EP claimed
US-7601785-B2 Sulphonated multiblock copolymer and electrolyte membrane using the same LG CHEM, LTD. (KR) 2009-10-13 US claimed
EP-1828284-A4 SULPHONATED MULTIBLOCK COPOLYMER AND ELECTROLYTE MEMBRANE USING THE SAME LG CHEMICAL LTD (KR) 2009-06-10 EP claimed
EP-1828284-A1 SULPHONATED MULTIBLOCK COPOLYMER AND ELECTROLYTE MEMBRANE USING THE SAME LG Chem Ltd. (KR) 2007-09-05 EP claimed
WO-2006065068-A9 SULPHONATED MULTIBLOCK COPOLYMER AND ELECTROLYTE MEMBRANE USING THE SAME LG CHEMICAL LTD (KR) 2007-06-07 WO claimed
US-20060160960-A1 Sulphonated multiblock copolymer and electrolyte membrane using the same LG CHEM, LTD. (KR) 2006-07-20 US claimed
WO-2006065068-A1 SULPHONATED MULTIBLOCK COPOLYMER AND ELECTROLYTE MEMBRANE USING THE SAME LG CHEM, LTD. (KR) 2006-06-22 WO claimed
US-20040225048-A1 Vibration damping material composition TITECS JAPAN CORPORATION (JP) 2004-11-11 US claimed
EP-1408075-A1 Vibration damping material composition Titecs Japan Corporation (JP) 2004-04-14 EP claimed
EP-0902326-B1 Novolak resin precursor, novolak resin and positive photoresist composition containing the novolak resin TOKYO OHKA KOGYO CO LTD (JP) 2003-11-26 EP claimed
US-6207788-B1 FROM 2,6-DIMETHYLOL-4-METHYLPHENOL AND BIS(2,5-DIMETHYL-4-HYDROXYPHENYL)METHANE TOKYO OHKA KOGYA CO., LTD. (JP) 2001-03-27 US claimed
EP-0902326-A2 Novolak resin precursor, novolak resin and positive photoresist composition containing the novolak resin TOKYO OHKA KOGYO CO., LTD. (JP) 1999-03-17 EP claimed
US-20260132242-A1 CURABLE RESIN, CURABLE RESIN COMPOSITION, AND CURED PRODUCT DIC CORPORATION (JP) 2026-05-14 US disclosed
US-20250122320-A1 CURABLE RESIN, CURABLE RESIN COMPOSITION, AND CURED ARTICLE DIC CORPORATION (JP) 2025-04-17 US disclosed
US-12157793-B2 Curable resin, curable resin composition, and cured product DIC CORPORATION (JP) 2024-12-03 US disclosed
US-20240317916-A1 CURABLE RESIN COMPOSITION AND CURED PRODUCT DIC CORPORATION (JP) 2024-09-26 US disclosed
US-4247662-A Novel halobisphenolethylene polycarbonate-vinyl aromatic resin blends GENERAL ELECTRIC COMPANY (US) 1981-01-27 US disclosed
US-4225687-A MOLDING MATERIALS GENERAL ELECTRIC COMPANY (US) 1980-09-30 US disclosed
US-4217438-A Polycarbonate transesterification process GENERAL ELECTRIC COMPANY (US) 1980-08-12 US disclosed
US-4118370-A ESTERIFIED HINDERED PHENOL; MOLDING MATERIALS, FIBERS, LAMINATES GENERAL ELECTRIC COMPANY (US) 1978-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132242-A1 CURABLE RESIN, CURABLE RESIN COMPOSITION, AND CURED PRODUCT ASH2L, ARL1, CARM1 ALDH1A1 370/4885HIF1A 693/4885HSD17B10 3347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.